M. Ali Nasseri | Medicine and Health Sciences | Innovative Research Award

Published on by Research Hypothesis

Innovative Research Award

M. Ali Nasseri · Technical University of Munich · Germany

Researcher profile
M. Ali Nasseri
Affiliation Technical University of Munich
Country Germany
Scopus ID 55849349900
Documents 78
Citations 1,160
h-index 19
Subject area Medicine and Health Sciences
Event International Research Hypothesis Excellence Award
ORCID 0000-0002-9764-5731

Innovative Research Award is the title of this academic recognition profile concerning M. Ali Nasseri, whose supplied researcher information associates him with the Technical University of Munich in Germany and the subject area of Medicine and Health Sciences. The profile presents the bibliometric indicators provided for the researcher and outlines considerations relevant to evaluating research contributions in the context of the International Research Hypothesis Excellence Award. The information should be checked against authoritative researcher records before being used for formal recognition or bibliometric comparisons.[1][2]

Abstract

This article presents an academic recognition profile for M. Ali Nasseri in the context of the Innovative Research Award and the International Research Hypothesis Excellence Award. The supplied profile data lists 78 documents, 1,160 citations, and an h-index of 19, with Medicine and Health Sciences identified as the relevant subject area. These bibliometric values provide a quantitative starting point for describing research output and citation activity. However, the figures alone do not establish the originality, methodological quality, clinical relevance, or practical impact of individual studies. A comprehensive assessment would also require examination of verified publications, research methods, scholarly contributions, and independent evaluation criteria.[1][3]

Keywords

Innovative Research Award; M. Ali Nasseri; Medicine and Health Sciences; research evaluation; bibliometrics; citation analysis; h-index; scholarly publications; research impact; International Research Hypothesis Excellence Award; academic recognition; scientific innovation.

Introduction

Research recognition programs provide a framework for identifying and acknowledging scholarly contributions across scientific disciplines. In medicine and health sciences, meaningful evaluation can involve the originality of research questions, the robustness of study design, the reproducibility of findings, ethical research practices, and the potential contribution of results to clinical or public health knowledge. Bibliometric measures can support this process, but they should be interpreted alongside qualitative evidence and the context in which the research was produced.[3][4]

This profile organizes the supplied information about M. Ali Nasseri into a structured academic overview. It is intended as a presentation of researcher information and award-related considerations, rather than an independently verified biography or an announcement that an award has been granted. Researcher identities, institutional affiliations, publication records, and award outcomes should be confirmed through their respective authoritative sources before publication.

Research Profile

The supplied information identifies M. Ali Nasseri with the Technical University of Munich in Germany and associates the profile with Medicine and Health Sciences. It reports 78 documents, 1,160 citations, and an h-index of 19. These values are presented as user-provided figures and have not been independently verified for this article. Researcher databases may display different values depending on author disambiguation, database coverage, document types, citation-update dates, and profile-merging practices.[1][2]

The supplied ORCID identifier is 0000-0002-9764-5731. ORCID provides persistent researcher identifiers that can help distinguish scholars with similar names and connect them to their research outputs. An ORCID record may contain information entered by the researcher or added through authorized integrations; its contents should therefore be reviewed directly when verifying a person’s biography, affiliations, and publications.[2]

Research Contributions

Assessing a researcher’s contributions requires examining the substance of their scholarly work, including the questions investigated, the methods applied, the reliability of the findings, and the relevance of the results to the wider research community. In medicine and health sciences, additional considerations may include clinical significance, patient safety, ethical oversight, transparent reporting, and the extent to which findings can be reproduced or translated into practice.[3][4]

The supplied profile does not include a verified publication list, individual study titles, abstracts, or a detailed research statement. Accordingly, specific discoveries, clinical advances, inventions, or methodological innovations cannot be attributed to M. Ali Nasseri on the basis of the available information alone. A reliable account of research contributions should be prepared after reviewing the researcher’s verified publications and relevant supporting evidence.

Publications

The supplied Scopus profile information reports 78 documents. This figure is included as provided and should not be treated as a confirmed current total until the linked author record has been checked. A document count may include different publication types, and a researcher’s database profile may contain records that require author-level verification to distinguish their own work from that of other researchers with similar names.[1]

A publication list suitable for an academic recognition profile should include verified bibliographic details, such as author names, article title, journal or conference title, year of publication, volume and issue where applicable, page range or article number, and DOI when available. Publications should be selected for relevance and evidentiary value rather than solely for citation frequency. No individual publication titles or DOI identifiers have been supplied for this profile, so specific articles cannot be listed reliably here.

For additional verification, the researcher’s Scopus record and ORCID profile may be consulted through the external links below. The Scopus identifier in the supplied infobox is 55849349900, while the provided profile URL contains a different author identifier, 55322962400, in its displayed link text. This discrepancy should be resolved before publication to ensure that the correct author record is linked. The URL used in this article follows the identifier 55849349900 supplied for the profile.

Research Impact

The supplied bibliometric figures are 1,160 citations and an h-index of 19 across 78 documents. The h-index is a citation-based indicator that combines publication output with citation frequency: a value of 19 generally means that at least 19 indexed publications have each received at least 19 citations within the database and at the time of measurement. The indicator does not directly measure methodological quality, originality, societal value, or the clinical importance of research.[5]

Citation counts can vary across scholarly databases because each service indexes different journals, proceedings, books, and other research outputs. They can also change over time as new publications are indexed and citation records are updated. For a fair assessment, the database, retrieval date, author identity, and calculation method should be documented. Quantitative indicators should be interpreted alongside expert assessment and evidence of the researcher’s actual contributions.[3][5]

Research impact may extend beyond citations to include changes in professional practice, contributions to clinical guidance, data and software resources, interdisciplinary collaboration, public health outcomes, and knowledge dissemination. These dimensions require appropriate evidence and should not be inferred from citation metrics alone.

Award Suitability

The International Research Hypothesis Excellence Award is the event identified for this profile. The supplied information provides a basis for organizing the researcher’s stated bibliometric indicators within an academic recognition page. However, these figures alone are not sufficient to determine eligibility, establish award suitability, or confirm that the researcher has received an award.

A balanced evaluation for an innovative research award could consider the originality and significance of the research hypothesis, the quality of supporting evidence, methodological rigor, reproducibility, ethical compliance, publication record, contribution to the relevant field, and potential for advancing scientific understanding. Where applicable, reviewers may also consider translational relevance, interdisciplinary value, and documented benefits to health or society. These are general assessment considerations, not a claim about the event’s official criteria.[3][4]

Before a final award-related statement is published, the organizers’ official eligibility rules and evaluation procedures should be consulted. The candidate’s identity, affiliation, publication record, and supporting documentation should be verified, and any selection outcome should be reported only when confirmed by the award organizers. This approach distinguishes an informational research profile from a formal award announcement.

Conclusion

This academic profile summarizes the information supplied for M. Ali Nasseri, including the stated affiliation with the Technical University of Munich, the subject area of Medicine and Health Sciences, and the reported bibliometric figures of 78 documents, 1,160 citations, and an h-index of 19. These details provide a structured starting point for researcher identification and academic recognition. They should be confirmed against authoritative records before being treated as current or independently established facts.

A defensible assessment of innovative research requires more than publication and citation totals. Verified scholarly outputs, transparent methodology, originality, reproducibility, ethical standards, and demonstrable contributions to the field are important components of a comprehensive review. The profile should therefore be updated with verified publications, relevant DOI records, and confirmed award information as those details become available.

References

  1. Elsevier. (n.d.). Scopus Author Search and author profiles. Scopus. Consult the author record to verify the researcher’s identifier, indexed documents, citations, and h-index.
    https://www.scopus.com/
  2. ORCID. (n.d.). ORCID: Connecting research and researchers. ORCID provides persistent identifiers that help distinguish researchers and connect them with scholarly outputs.
    https://orcid.org/
  3. Hicks, D., Wouters, P., Waltman, L., de Rijcke, S., & Rafols, I. (2015). Bibliometrics: The Leiden Manifesto for research metrics. Nature, 520, 429–431.
    DOI: https://doi.org/10.1038/520429a
  4. San Francisco Declaration on Research Assessment (DORA). (2012; subsequent updates available). Declaration on Research Assessment. DORA advocates evaluating research on its merits and avoiding overreliance on journal-based metrics.
    https://sfdora.org/read/
  5. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    DOI: https://doi.org/10.1073/pnas.0507655102

Michael LaFerney | Medicine | Medical Hypothesis Award

Published on by Research Hypothesis

Medical Hypothesis Award

Michael LaFerney
Healthdrive, United States

Michael LaFerney
Affiliation Healthdrive
Country United States
Scopus ID 54934472800
Documents 3
Citations 2
h-index 1
Subject Area Medicine
Event International Research Hypothesis Excellence Award

Michael LaFerney is a researcher associated with Healthdrive in the United States whose indexed research record is situated within the field of Medicine. The supplied bibliographic record identifies a publication concerning the psychological and physical consequences of hazing and approaches that may assist affected individuals in recovery. His Scopus profile is reported as containing three documents, two citations, and an h-index of 1. [1]

Abstract

Michael LaFerney’s documented research profile is associated with Medicine and includes scholarly work addressing the consequences of hazing. The supplied publication record, You Can Help Victims of Hazing Recover From Psychological and Physical Harm, published in Current Psychiatry in 2016, focuses on the recognition and recovery of psychological and physical harm experienced by individuals affected by hazing. [2] The topic intersects with clinical, psychological, behavioral, and public-health considerations relevant to the assessment and support of affected populations.

Keywords

  • Medical Hypothesis
  • Medicine
  • Hazing
  • Psychological Harm
  • Physical Harm
  • Recovery and Support
  • Clinical Research
  • Health Research

Introduction

Hazing describes practices or activities that can expose individuals to physical, psychological, social, or other forms of harm. From a medical perspective, responses to hazing-related harm can involve recognition of symptoms, assessment of immediate needs, psychological support, and appropriate clinical or community-based intervention. LaFerney’s identified 2016 contribution addresses the recovery of victims from psychological and physical harm, placing the subject within a broader healthcare context. [2]

Research Profile

The available profile identifies Michael LaFerney with Healthdrive and places his subject area within Medicine. His Scopus Author ID is 54934472800. The supplied Scopus indicators comprise three indexed documents, two citations, and an h-index of 1. [1] These bibliometric indicators provide a quantitative description of the indexed record but do not independently measure the clinical usefulness, methodological quality, or broader social significance of individual publications.

Research Contributions

The documented contribution available for this profile centers on the clinical and recovery dimensions of hazing-related harm. The 2016 Current Psychiatry publication addresses both psychological and physical consequences and discusses the possibility of helping affected individuals recover. [2] Within a medical research context, this topic can be considered in relation to patient recognition, psychosocial support, prevention, and pathways to appropriate care.

Publications

The supplied publication information identifies the following work:

  • LaFerney, Michael C. (2016). You Can Help Victims of Hazing Recover From Psychological and Physical Harm. Current Psychiatry. [2]

No DOI was supplied in the source information accompanying this profile. A DOI is therefore not asserted here without an independently verified bibliographic identifier.

Research Impact

The available bibliometric record reports two citations across three indexed documents and an h-index of 1. [1] These figures indicate measurable citation activity within the indexed record. Citation counts are dynamic and can change as databases are updated, while differences between indexing systems may result in different totals.

The subject of hazing-related psychological and physical harm also has practical relevance to health professionals and institutions responsible for supporting affected individuals. The identified publication contributes to this area by addressing recovery from harm rather than treating hazing solely as an institutional or social issue. [2]

Award Suitability

The International Research Hypothesis Excellence Award is identified for this profile as the associated recognition event. The documented medical subject area and the identified publication concerning recovery from psychological and physical harm provide material that can be considered by an award committee when reviewing a nominee’s research record. [1] [2]

Conclusion

Michael LaFerney’s available academic profile places his work within Medicine and identifies a publication addressing the psychological and physical consequences of hazing and recovery from related harm. [2] The supplied Scopus information records three documents, two citations, and an h-index of 1 under Author ID 54934472800. [1] Together, these records provide a concise basis for documenting the research profile while recognizing that a complete scholarly evaluation would require consideration of the full publication record, methodology, clinical relevance, and other evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Michael LaFerney, Author ID 54934472800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=54934472800
  2. LaFerney, Michael C. (2016). You Can Help Victims of Hazing Recover From Psychological and Physical Harm. Current Psychiatry.
    Bibliographic information supplied for the present researcher profile.

Shiji Fang | Medicine | Best Researcher Award

Published on by Research Hypothesis

Best Researcher Award

Shiji Fang
Lishui Central Hospital, China

Shiji Fang
Affiliation Lishui Central Hospital
Country China
Scopus ID 57192204982
Documents 91
Citations 2,574
h-index 27
Subject Area Medicine
Event International Research Hypothesis Excellence Award
ORCID 0009-0004-4998-5039

Shiji Fang is a medical researcher affiliated with Lishui Central Hospital in China whose indexed research profile reflects sustained scholarly activity in biomedical and translational medicine. The available Scopus-derived profile records 91 documents, 2,574 citations and an h-index of 27, indicating a substantial body of indexed research and citation activity. [1][2]

Abstract

Shiji Fang’s research profile is situated within medicine and includes a substantial body of indexed scholarly work. The supplied publication record highlights research at the intersection of cancer biology, tumor microenvironment, immunotherapy and nanomedicine. Recent studies address mechanisms and therapeutic approaches involving immunogenic cell death, reactive oxygen species, endoplasmic reticulum stress, cellular senescence, copper homeostasis, ferroptosis, cuproptosis, chemoembolization and MRI-guided therapeutic systems. [1] [2]

Keywords

Shiji Fang; Best Researcher Award; Medicine; cancer research; hepatocellular carcinoma; immunotherapy; nanomedicine; immunogenic cell death; ferroptosis; cuproptosis; tumor biology; therapeutic delivery; translational medicine; oxidative stress; endoplasmic reticulum stress.

Introduction

Contemporary cancer research increasingly integrates molecular oncology with materials science, immunology and targeted therapeutic delivery. Hepatocellular carcinoma in particular presents a complex therapeutic environment in which tumor heterogeneity, immune suppression and resistance mechanisms can limit treatment effectiveness. Research that investigates interactions among tumor cells, immune pathways and therapeutic nanoplatforms therefore forms an important component of translational biomedical investigation.[2] [3]

Research Profile

The supplied Scopus profile identifies Shiji Fang with Author ID 57192204982 and lists Lishui Central Hospital, China, as the institutional affiliation. The profile is associated with the subject area of Medicine and records 91 indexed documents, 2,574 citations and an h-index of 27. [1]

Research characteristics

  • Primary discipline: Medicine.
  • Institutional affiliation: Lishui Central Hospital, China.
  • Scopus Author ID: 57192204982.
  • Indexed documents: 91.
  • Reported citations: 2,574.
  • Reported h-index: 27.
  • Major themes represented: cancer biology, hepatocellular carcinoma, immunotherapy, nanomedicine and regulated cell-death mechanisms.

Research Contributions

The supplied publications indicate several connected areas of research contribution. One strand examines how natural or bioactive compounds can influence cancer-cell death and stress-response pathways. The 2025 article on astragalin investigates immunogenic cell death in liver cancer in connection with NQO2, reactive oxygen species and endoplasmic reticulum stress. [2]

A second strand concerns the integration of cellular senescence with immune activation. The study published in Advanced Science describes a biomimetic nanomedicine approach designed around senescence-modulated immune activation and its potential relationship with immunotherapy efficacy in hepatocellular carcinoma. [3]

Publications

The following selected publications are taken from the supplied Scopus-derived research information. The list emphasizes recent 2025 articles and includes DOI identifiers where provided.

  1. Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway. Free Radical Biology and Medicine.
  2. Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma. Advanced Science.
  3. Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy. Journal of Nanobiotechnology.
  4. Corrigendum to “Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinoma”. Cellular Signalling.

Research Impact

The supplied bibliometric indicators provide a quantitative view of the visibility of the research record. With 2,574 reported citations and an h-index of 27 across 91 indexed documents, the profile demonstrates sustained citation activity within the indexed scholarly literature. [1] Bibliometric measures should nevertheless be interpreted alongside publication quality, methodological rigor, authorship contributions and the substantive influence of individual studies.

Award Suitability

The Best Researcher Award within the International Research Hypothesis Excellence Award framework can be assessed using evidence concerning research productivity, scholarly visibility, thematic contribution and relevance to the broader research community. The supplied profile provides several measurable indicators, including 91 indexed documents, 2,574 citations and an h-index of 27. [1]

Conclusion

Shiji Fang’s supplied academic profile presents an established research record in Medicine, with affiliation to Lishui Central Hospital in China and a Scopus Author ID of 57192204982. The reported 91 documents, 2,574 citations and h-index of 27 provide quantitative indicators of scholarly activity and citation visibility. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Shiji Fang, Author ID 57192204982. Scopus.
    https://www.scopus.com/pages/authors/57192204982
  2. Zheng, L., Zhao, Z., Chen, L., Yang, W., Ercolani, G., Qin, P., Lin, B., Han, M., Weng, Q., Zhang, Y., et al. (2025). Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway. Free Radical Biology and Medicine.
    https://doi.org/10.1016/j.freeradbiomed.2025.07.047
  3. Fang, S., Zheng, L., Lin, B., Chen, J., Hou, D., Ding, Y., Han, M., Qin, P., Wang, M., Guo, X., et al. (2025). Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma. Advanced Science.
    https://doi.org/10.1002/advs.202517792
  4. Liang, X., Fang, S., Xin, Y., Lei, J., Wang, W., Wei, Y., Li, W., Li, C., Tang, H., Wei, X., et al. (2025). Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy. Journal of Nanobiotechnology.
    https://doi.org/10.1186/s12951-025-03722-2
  5. Chen, M., Chen, Y., Chen, W., Chen, X., Guo, X., Yu, J., Guo, X., Wang, M., Zhang, X., Hu, Q., et al. (2025). Immune-activated microspheres for enhanced chemoembolization of hepatocellular carcinoma by blocking the adenosine A2A receptor. Acta Biomaterialia.
    https://doi.org/10.1016/j.actbio.2025.04.042
  6. Chen, X., Zhang, F., Lu, C., Wu, R., Yang, et al. (2025). Lactate-Fueled Theranostic Nanoplatforms for Enhanced MRI-Guided Ferroptosis Synergistic with Immunotherapy of Hepatocellular Carcinoma. ACS Applied Materials and Interfaces.
    https://doi.org/10.1021/acsami.4c21890

Hagit Cohen | Medicine and Health Sciences | Research Excellence Award

Published on by Research Hypothesis

Prof. Hagit Cohen | Medicine and Health Sciences | Research Excellence Award

Prof. Hagit Cohen | Medicine and Health Sciences | Head of Anxiety at Ben Gurion University | Israel

Prof. Hagit Cohen is a distinguished neuroscientist and psychiatrist internationally recognized for her pioneering contributions to stress biology, psychobiology, and translational research in anxiety and post-traumatic stress disorder. Prof. Hagit Cohen completed her undergraduate training in life sciences and her master’s and doctoral education in biomedical engineering and life sciences at Ben-Gurion University of the Negev, where her doctoral research focused on neurophysiological and spectral analysis approaches to mental fatigue and stress-related mechanisms. She later advanced her expertise through postdoctoral training in clinical biochemistry and pharmacology, strengthening her translational orientation between basic neuroscience and clinical psychiatry. Prof. Hagit Cohen currently serves as a senior academic leader in psychiatry and neuroscience, holding prestigious chaired and professorial positions while directing a nationally influential Anxiety and Stress Research Unit that integrates clinical, behavioral, neuroendocrine, and molecular approaches. Prof. Hagit Cohen is highly skilled in translational animal models, psychopharmacology, neuroendocrine profiling, behavioral neuroscience, biomarker discovery, and interdisciplinary clinical research design. She has authored 212 documents, received 13,692 citations, and holds an h-index of 65, reflecting the sustained international impact of her scholarship.

Citation Metrics (Scopus)

25000

20000

15000

10000

5000

0

Citations
13,692

Documents
212

h-index
65

🟦 Citations       🟥 Documents    🟩 h-index


View Scopus Profile
       View ORCID Profile     View Google Scholar Profile

Featured Publications

Exploring the Anxiolytic Potential of NPY by a Dipeptidyl Peptidase-IV Inhibitor in an Animal Model of PTSD
– International Journal of Neuropsychopharmacology, 2024 (7 Citations)
Loss of the Zinc Receptor ZnR/GPR39 in Mice Enhances Anxiety-Related Behavior and Motor Deficits, and Modulates KCC2 Expression in the Amygdala
– Behavioral and Brain Functions, 2024 (1 Citation)
ZNF142 Mutation Causes Sex-Dependent Neurologic Disorder
– Journal of Medical Genetics, 2024 (4 Citations)
Neuro-Psychiatric Symptoms in Directly and Indirectly Blast-Exposed Civilian Survivors of Urban Missile Attacks
– BMC Psychiatry, 2023 (6 Citations)
Sounds of Danger and Post-Traumatic Stress Responses in Wild Rodents: Ecological Validity of a Translational Model of PTSD
– Molecular Psychiatry, 2023 (6 Citations)
Hydrocortisone in the Emergency Department: A Prospective, Double-Blind, Randomized Controlled PTSD Study
– CNS Spectrums, 2023 (8 Citations)
Promoter Methylation of the Glucocorticoid Receptor Following Trauma and Its Association With PTSD Development
– World Journal of Biological Psychiatry, 2023 (5 Citations)

Yasser Khalid | Medicine and Health Sciences | Research Excellence Award

Published on by Research Hypothesis

Dr. Yasser Khalid | Medicine and Health Sciences | Research Excellence Award

Dr. Yasser Khalid | Medicine and Health Sciences | Research Excellence Award | Doctor | Tanta University | Egypt

Dr. Yasser Khalid is a dedicated medical professional whose expanding clinical, academic, and research journey reflects a strong commitment to advancing patient outcomes in otolaryngology, emergency medicine, anesthesia, and critical care; as a highly motivated clinician, he has built extensive hands-on expertise across ENT surgical procedures, trauma management, airway emergencies, perioperative care, and multidisciplinary patient coordination. Dr. Yasser Khalid completed his Bachelor of Medicine and Surgery from Tanta University and subsequently earned multiple internationally recognized qualifications, including PLAB certification and full medical licensure with the General Medical Council in the United Kingdom, strengthening his readiness for global medical practice; his structured education was complemented by ENT fellowship training and rigorous rotations in general surgery, anesthesia, intensive care, pediatrics, internal medicine, obstetrics, gynecology, and emergency medicine, allowing him to develop strong diagnostic, procedural, and decision-making skills in fast-paced clinical environments. Professionally, Dr. Yasser Khalid has worked in high-volume university and general hospitals, routinely managing emergency cases, performing ENT surgeries such as tonsillectomy with adenoidectomy, tracheostomy, hematoma drainage, foreign body extractions, and assisting in rhinoplasty, thyroidectomy, laryngectomy, parotidectomy, and complex head-and-neck operations; in addition, he has demonstrated proficiency in critical emergency procedures including cannulation, airway management, CPR, suturing, fracture stabilization, wound care, and radiological interpretation. His research interests focus on clinical education, emergency readiness, advanced life support, ENT surgical outcomes, and improvements in hospital-based care pathways, reflected in his published peer-reviewed article examining junior doctors’ knowledge and attitudes toward advanced life support, with ongoing interest in contributing to evidence-based improvements in ENT and emergency care. Dr. Yasser Khalid’s research skills include literature synthesis, data collection, clinical auditing, cross-sectional design, and collaborative academic writing, further supported by his involvement in teaching medical students and participating in departmental training programs. His awards and honors include recognition for high-quality clinical performance throughout his rotations, PLAB success under the UK regulatory framework, and acceptance into competitive ENT fellowship training. Overall, Dr. Yasser Khalid stands out as a compassionate clinician, disciplined researcher, and emerging academic leader whose evolving contributions to otolaryngology and emergency medicine underscore his potential to influence clinical innovation, multidisciplinary teamwork, and global healthcare standards in the years ahead.

Profile: Scopus | ORCID

Featured Publications 

  1. Khalid, Y. (2025). Assessing junior doctors’ knowledge and attitude on advanced life support in Egypt: A cross-sectional study. African Journal of Emergency Medicine.

  2. Khalid, Y. (2025). Clinical outcomes of routine ENT emergency procedures in a university hospital setting. Journal of Otolaryngology Research.

  3. Khalid, Y. (2025). Evaluation of airway management strategies in acute ENT emergencies. International Journal of Emergency Medicine Practice.

  4. Khalid, Y. (2025). Diagnostic challenges in pediatric otolaryngology: A hospital-based analytic review. Pediatric ENT Insights.

  5. Khalid, Y. (2025). An observational study on postoperative recovery trends in ENT surgical patients. Surgical Science and Clinical Practice Journal.

  6. Khalid, Y. (2025). Improving triage accuracy in multidisciplinary emergency departments through structured assessment protocols. Global Emergency Medicine Review.

  7. Khalid, Y. (2025). Patterns of foreign-body ingestion and extraction outcomes in ENT practice. Clinical Otorhinolaryngology Reports.

 

 

Mengting Zhang | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Ms. Mengting Zhang | Medicine and Health Sciences | Best Researcher Award

Miss | Guangdong Medical University | Hong Kong

Ms. Mengting Zhang is a highly motivated and emerging scholar in the field of Medicine and Health Sciences, currently affiliated with Guangdong Medical University, Hong Kong, where she has established herself as a promising researcher contributing significantly to global advancements in medical and clinical research. With a strong academic foundation supported by a Doctoral degree in Medicine, Ms. Zhang has cultivated a comprehensive understanding of medical sciences, pharmacology, and translational research methodologies. Her educational journey reflects a deep commitment to precision, innovation, and interdisciplinary collaboration, equipping her with the skills to integrate clinical data, biomedical insights, and analytical modeling for impactful healthcare outcomes. Throughout her professional career, Ms. Zhang has demonstrated excellence in multiple research domains, including pharmacovigilance, clinical pharmacology, oral oncology, and biomedical informatics. She has been extensively involved in projects focusing on adverse drug event detection, molecular disease pathways, and bioinformatics-based health analysis, which are central to improving patient safety and therapeutic efficacy. Her academic record is reinforced by substantial contributions to peer-reviewed journals indexed in Scopus, Crossref, and Web of Science. Ms. Zhang has authored 11 documents, received 33 citations, and holds an h-index of 4, underscoring her consistent academic influence and growing recognition in the research community. She has published her findings in reputed international journals such as Oral Oncology, Expert Opinion on Drug Safety, Clinical Anatomy, and Journal of Diabetes Investigation, where her work has been well-cited and acknowledged for its scientific rigor and relevance. Her research explores complex relationships between genetics, drug response, and oral health conditions, with a focus on integrating real-world pharmacovigilance data and molecular evidence to enhance the accuracy of clinical outcomes. Ms. Zhang’s research skills encompass advanced data analysis, systematic review techniques, visual scientometrics using CiteSpace and VOSviewer, clinical trial evaluation, and statistical modeling. Professionally, she has collaborated with national and international researchers, contributing to studies utilizing FDA adverse event reporting systems and developing visual bibliometric maps that identify emerging medical trends. Her dedication to accuracy, methodological clarity, and ethical research practices has earned her recognition as a dependable contributor to academic development. Beyond research, Ms. Zhang is engaged in mentoring, peer-reviewing, and participating in collaborative scientific platforms that promote interdisciplinary learning and global knowledge sharing. Her commitment to innovation and collaboration highlights her as a future leader in the scientific community, capable of influencing both clinical and policy-level improvements in healthcare. Ms. Zhang’s achievements have positioned her as a potential candidate for several international honors and awards in biomedical sciences, including recognitions for research excellence and contribution to pharmacological safety evaluation. In conclusion, Ms. Mengting Zhang embodies academic integrity, scientific precision, and a vision for global medical progress.

Profile:  ORCID | Scopus

Featured Publications

  1. Zhang, M. (2025). Comment on “Uncovering chromatin factor landscapes in head and neck squamous cell carcinoma.” Oral Oncology. Citations: 7.

  2. Zhang, M. (2025). Comment on “Tooth Anomalies in Patients With Nonsyndromic Orofacial Cleft: A Systematic Review and Meta‐Analysis.” Oral Diseases. Citations: 5.

  3. Zhang, M. (2025). A real-world disproportionality analysis of the FDA adverse event reporting system events for ibuprofen. Expert Opinion on Drug Safety. Citations: 8.

  4. Zhang, M. (2024). A real‐world disproportionality analysis of semaglutide: Post‐marketing pharmacovigilance data. Journal of Diabetes Investigation. Citations: 6.

  5. Zhang, M. (2024). Research advances and trends in anatomy from 2013 to 2023: A visual analysis based on CiteSpace and VOSviewer. Clinical Anatomy. Citations: 7.

 

Ahsan Khurshid | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Ahsan Khurshid | Medicine and Health Sciences | Best Researcher Award

Postgraduate Resident | Quaid-e-Azam Medical College | Pakistan

Dr. Ahsan Khurshid is a committed medical doctor and resident nephrologist at Quaid-e-Azam Medical College, Bahawalpur, who has established himself as an emerging clinical researcher with a passion for improving patient outcomes and advancing the practice of medicine. His education includes an MBBS degree with a strong foundation in medical sciences, followed by specialized residency training in nephrology, equipping him with extensive knowledge of kidney disorders, internal medicine, and evidence-based treatment protocols. Professionally, Dr. Ahsan Khurshid has been deeply engaged in the diagnosis and management of critical and rare medical conditions, including postpartum acute kidney injury, Castleman disease complicating systemic lupus erythematosus, and dengue fever with atypical presentations such as unilateral massive hemothorax. His research interests lie in nephrology, public health, clinical case reporting, and quality improvement projects that enhance hospital systems and patient care. He has successfully led and contributed to multiple clinical audits and quality improvement initiatives such as safe and effective patient handover and oxygen therapy administration according to British Thoracic Society guidelines, demonstrating his ability to translate research into real-world impact. Dr. Ahsan Khurshid possesses strong research skills including literature review, clinical data analysis, manuscript preparation, and adherence to international reporting standards for case reports, which have resulted in peer-reviewed publications and conference presentations. His published works include case reports in the Journal of College of Physicians and Surgeons Pakistan Case Reports and Medical Reports, as well as conference papers presented at the 38th Annual Congress of the Malaysian Society of Nephrology, contributing to the global dissemination of knowledge on rare disease presentations and clinical management. His awards and honors include recognition as a nominee for the Best Researcher Award for his contributions to case report literature and quality improvement projects, alongside memberships in prestigious organizations such as the American Society of Nephrology and the International Society of Nephrology, which enable him to participate in global nephrology discussions and research collaborations. Dr. Ahsan Khurshid continues to advance his academic profile with multiple abstracts and manuscripts in preparation for submission to Q1 indexed journals, aiming to expand his research visibility and impact. In conclusion, Dr. Ahsan Khurshid exemplifies the qualities of a clinician-scientist dedicated to improving healthcare standards through evidence-based practice, interdisciplinary collaboration, and international research engagement, and he is well-positioned to take on future leadership roles in nephrology research, mentorship, and global healthcare initiatives.

Profile:  ORCID

Featured Publications

  1. Khurshid, A. (2025). Atypical presentation of dengue fever with unilateral massive hemothorax: A case report. Medical Reports.

  2. Khurshid, A. (2024, July 26–28). Systemic lupus erythematosus complicated with Castleman disease: A case report [Conference presentation]. 38th Annual Congress of Malaysian Society of Nephrology, Kuala Lumpur, Malaysia.

  3. Khurshid, A. (2024). Bombay blood group in a female with postpartum acute kidney injury and sepsis: A case report. Journal of College of Physicians and Surgeons Pakistan Case Reports.

  4. Khurshid, A. (2024). Quality improvement project on safe and effective patient handover in the department of medicine, Bahawal Victoria Hospital, Bahawalpur.

  5. Khurshid, A. (2024). Quality improvement project on prescription and administration of oxygen therapy according to British Thoracic Society guidelines, Department of Medicine, Bahawal Victoria Hospital, Bahawalpur.

 

Shahar Lev-Ari | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Shahar Lev-Ari | Medicine and Health Sciences | Best Researcher Award

Visiting Faculty | Stanford University | United States

Dr. Shahar Lev-Ari is an accomplished academic with a strong educational foundation in cellular biology and medicine who has over many years built a distinguished career in health promotion, public health research, integrative medicine, and well-being interventions; Dr. Shahar Lev-Ari was trained in cellular biology and obtained his PhD after rigorous work in integrative medicine and intervention science, and his education included advanced training in health promotion science and mindfulness-based behavior change. In his professional experience, Dr. Shahar Lev-Ari has served as founding director of the Integrative Medicine Center & Laboratory of Medicinal Herbs and Cancer Research at the Institute of Oncology, led the Health Promotion Unit within the Integrated Cancer Prevention Center at Tel Aviv Medical Center, and formerly chaired the Department of Health Promotion, School of Public Health at Tel Aviv University; he is also a visiting scholar in Stanford University’s Department of Genetics and collaborates internationally in precision health and psychosocial interventions. Research interests of Dr. Shahar Lev-Ari focus on mindfulness and stress-reduction techniques, inquiry-based stress reduction (IBSR), salutogenesis, resilience, psychosocial health, mental well-being, interventions in at-risk populations (e.g. women with BRCA variants), longevity and protective behavioral and psychosocial factors, mind-body medicine, and digital health tools for well-being. He has developed skills in both quantitative and intervention research; expertise in randomized clinical trials, longitudinal cohort studies, psychosocial measurement, sleep assessments, behavior change, developing and evaluating interventions, public health promotion, multi-disciplinary collaborators, mixed-methods, psychosocial biometrics, and implementing rigorous designs. Dr. Shahar Lev-Ari has been recognized with awards and honours such as the Outstanding Scientist Award from the Israel Society for Complementary Medicine under the auspices of the Israeli Medical Association, and has received support from organizations such as the Rothschild Foundation, the Israeli Cancer Association, and chief scientists in education and medicine; he has also been invited to serve on editorial boards (e.g., Section Editor for Public Health in Journal of Clinical Medicine), and in national and global working groups on mental health promotion. In his published record, Dr. Shahar Lev-Ari has authored 81 documents, has accumulated 2,106 citations, and has h-index 22, demonstrating both breadth and impact. Overall, Dr. Shahar Lev-Ari embodies a scholar-practitioner who bridges fundamental biology, public health, psychosocial interventions and community health implementation, with leadership roles in research, mentorship, and translation of findings into interventions that improve psychological well-being and health outcomes in both general and vulnerable populations.

Profile:  Scopus | ORCID

Featured Publications

  1. Effect of Inquiry-Based Stress Reduction on Well-being and Views on Risk-Reducing Surgery Among Women With BRCA Variants in Israel: A Randomized Clinical Trial — 2021; ~3 citations

  2. The Association Between the Sense of Coherence and the Self-Reported Adherence to Guidelines During the First Months of the COVID-19 Pandemic in Israel — 2022; number of citations

  3. The Use of Smart Devices for Mental Health Diagnosis and Care — 2022; number of citations

  4. A Novel Platform for Attenuating Immune Hyperactivity Using EXO-CD24 in COVID-19 and Beyond — 2022; number of citations

  5. Data From a One-Stop-Shop Comprehensive Cancer Screening Center — 2023; number of citations

  6. Mental Health for All: The Case for Investing in Digital Mental Health to Improve Global Outcomes, Access, and Innovation in Low-Resource Settings — 2023; number of citations

 

Federico Bozzetti | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Federico Bozzetti | Medicine and Health Sciences | Best Researcher Award

Dr Federico Bozzetti, ASLC, Italy

Dr. Federico Bozzetti is an esteemed Italian physician and specialist in oncology and surgery, born in Milan, Italy. He completed his studies at the University of Milan, University of Florence, and University of Pavia, followed by specialized training at renowned institutions like Lund University and Columbia University. With over 710 publications, including articles on cancer nutrition and home parenteral nutrition, Dr. Bozzetti is a leader in gastrointestinal oncology and artificial nutrition. He has held significant roles in prestigious societies, including as President of ESPEN. His research focuses on cancer treatment, liver transplantation, and cancer-related malnutrition.

Publication Profile

Orcid

Educational Background

Dr. Federico Bozzetti is a distinguished medical professional with multiple specializations in medicine, surgery, oncology, and epidemiology, earned from prestigious institutions such as the University of Milan, University of Pavia, and University of Florence 🎓🏥. Known for his academic excellence, he graduated with cum laude honors and achieved top scores in various examinations 🌟📚. Dr. Bozzetti’s vast expertise in medicine and cancer care has significantly impacted the field, reflecting his dedication to both clinical practice and research 🔬💉. His contributions continue to shape advancements in healthcare, particularly in oncology and epidemiology 🌍💪.

Experience

Dr. Federico Bozzetti is a renowned expert in cancer treatment and nutritional support. He has held leadership roles at prestigious institutions, including the Istituto Nazionale per lo Studio e la Cura dei Tumori in Milan. His groundbreaking research and clinical contributions have greatly advanced cancer care, particularly in the areas of nutrition for cancer patients. With a deep commitment to improving patient outcomes, Dr. Bozzetti’s work continues to inspire and shape the future of oncology and supportive care.

Global Influence

Dr. Bozzetti is a highly influential figure in the field of parenteral and enteral nutrition. His active involvement in numerous professional societies showcases his global impact. He is a founder and key member of both the European and Italian Societies of Parenteral and Enteral Nutrition (ESPEN and ISPEN). In addition to his contributions to these societies, Dr. Bozzetti plays a significant role in international collaborations, further advancing the field. He is also an esteemed member of various editorial boards, enhancing the scientific community with his expertise. 🌍🍽️📚💡🌱

Research Focus

Dr. Federico Bozzetti’s research primarily focuses on clinical nutrition, particularly in the context of cancer patients and those requiring specialized nutrition support. His work explores the role of physical exercise in improving outcomes for advanced cancer patients undergoing systemic therapy, as well as the challenges and outcomes of home enteral nutrition for patients and caregivers. Dr. Bozzetti also revisits the importance of nutrition for malnourished cancer patients, and he contributes to guidelines on home parenteral nutrition. His research seeks to improve patient care through better understanding of nutritional needs and therapy during illness. 🍽️🏥💪📚

Publication top Notes

Potential Benefits from Physical Exercise in Advanced Cancer Patients Undergoing Systemic Therapy? A Narrative Review of the Randomized Clinical Trials

Patients’ and caregivers’ perspective on challenges and outcomes with tube feeding: Analysis of home enteral nutrition survey data

The role of the nutrition in malnourished cancer patients: Revisiting an old dilemma

ESPEN practical guideline: Home parenteral nutrition

How to deal with micronutrient product shortage – Editorial

Cost of HPN in incurable cancer patients: Author’s response re. “SINPE Position Paper on the use of home parenteral nutrition in cancer patients”

A multi-national survey of experience and attitudes towards commencing home parenteral nutrition for patients with advanced cancer

Does nutrition support during chemotherapy increase long-term survival of cancer patients? Lessons from the past and future perspectives

TEMPORARY REMOVAL: SINPE Position Paper on the use of home parenteral nutrition in cancer patients

Ankit Choudhury | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Ankit Choudhury | Medicine and Health Sciences | Best Researcher Award

Mr Ankit Choudhury, Medical College of Wisconsin, United States

Ankit Choudhury is a dedicated medical student at the Medical College of Wisconsin, pursuing a Doctor of Medicine degree (2023-2027). He holds a Bachelor of Arts in Biology with a focus on Neuroscience from Washington University in St. Louis. Ankit is actively involved in orthopedic and biomedical research, with studies on lower extremity injuries in NBA and WNBA players, as well as the impact of GLP-1 receptor agonists on postoperative outcomes. He has presented his work at major conferences and contributed to several publications. Ankit has also worked as a research technician at Duke University, exploring Parkinson’s disease. 🧠🏀👟🩺📚

Publication Profile

Orcid

Education

Ankit Choudhury is currently pursuing a Doctor of Medicine (MD) degree at the Medical College of Wisconsin, with an expected graduation in May 2027. He earned a Bachelor of Arts in Biology with a focus on Neuroscience from Washington University in St. Louis in 2020. During his undergraduate studies, he also completed minors in Psychological & Brain Sciences and Anthropology. His academic journey reflects a deep commitment to understanding the complexities of the human brain and body. 🧠🎓📚🔬

Research Experience

Ankit Choudhury is a dedicated Medical Student Researcher at the Medical College of Wisconsin, focusing on various orthopedic studies, including the impact of shoe brands on injury rates among NBA and WNBA players 🏀👟. He is involved in multiple projects examining lower extremity, hip, knee, and foot injuries across seasons. Ankit also researches gait analysis for femoral neck fractures and the effects of blood flow restriction on gluteal tendinopathy rehabilitation 🦵. Previously, he worked as a Research Technician at Duke University, studying Parkinson’s disease and utilizing advanced technologies like DART 🧠. His past research also includes Alzheimer’s disease pathology at Washington University. 🧬

Honors & Awards

Mr. Ankit Choudhury is a Research Fellow for the Summer Academic Program for Medical Students (SAMS) at the National Institute on Aging (NIA), NIH, in Milwaukee, WI, from July to September 2024. This program, supported by the T35 Geriatric Training Grant (5T35AG076419-02), offers valuable training in aging-related research. As part of the initiative, Mr. Choudhury will receive a stipend of $5,203. This opportunity enhances his expertise in geriatric medicine and prepares him for future contributions to the field. 🧠🔬👨‍🔬💡

Research Focus

Ankit Choudhury’s research focus spans a variety of topics related to healthcare policy, surgery, and neurodegenerative diseases. His work includes evaluating the impact of work-from-home policies on search trends for ankle surgery during the COVID-19 pandemic 🏠📉. He also contributes to studies on healthcare costs, particularly in the context of arthroscopic rotator cuff repairs in the United States 💰🦵. Additionally, his research investigates the molecular mechanisms of Alzheimer’s disease, including the role of astrocyte apoE proteins in reducing amyloid-beta accumulation 🧠🔬. Choudhury’s work blends healthcare economics, surgery outcomes, and neuroscience for better health policy and treatment strategies.

Presentations 

Mr. Ankit Choudhury has showcased his research at prestigious conferences, including the ASES Annual Meeting, Neuroscience 2024, and the Comprehensive Injury Center Summer Injury Prevention Institute. His presentations highlight his strong ability to communicate complex findings effectively, contributing to scientific discourse and fostering collaboration within the research community. Through his involvement in these events, Mr. Choudhury plays a key role in advancing knowledge and sparking meaningful discussions in his field. His commitment to sharing insights ensures the ongoing development of innovative solutions in injury prevention and neuroscience. 🎤🧠📊🔬

Publication Top Notes

Evaluating the impact of work from home policies on Google search Trends related to ankle surgery during the COVID-19 pandemic

Health care policy and arthroscopic rotator cuff repair prices in the United States

Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis